A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib.
作者： Akihiro Tamiya , Shigeki Shimizu , Shinji Atagi
DOI: 10.1097/JTO.0000000000000575
关键词:
摘要:
jto.org
sci-hub.se 参考文章(5)
Akihiko Yoshida, Koji Tsuta, Shun-ichi Watanabe, Ikuo Sekine, Masashi Fukayama, Hitoshi Tsuda, Koh Furuta, Tatsuhiro Shibata, Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component. Lung Cancer. ,vol. 72, pp. 309- 315 ,(2011) , 10.1016/J.LUNGCAN.2010.09.013
Daisy Wing-Sze Wong, Elaine Lai-Han Leung, Kimpton Kam-Ting So, Issan Yee-San Tam, Alan Dart-Loon Sihoe, Lik-Cheung Cheng, Kwok-Keung Ho, Joseph Siu-Kie Au, Lap-Ping Chung, Maria Pik Wong, , The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer. ,vol. 115, pp. 1723- 1733 ,(2009) , 10.1002/CNCR.24181
Kazuya Takamochi, Kengo Takeuchi, Takuo Hayashi, Shiaki Oh, Kenji Suzuki, A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients PLoS ONE. ,vol. 8, pp. e69794- ,(2013) , 10.1371/JOURNAL.PONE.0069794
Justin A Bishop, Julie Teruya-Feldstein, William H Westra, Giuseppe Pelosi, William D Travis, Natasha Rekhtman, p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Modern Pathology. ,vol. 25, pp. 405- 415 ,(2012) , 10.1038/MODPATHOL.2011.173
Takashi Seto, Katsuyuki Kiura, Makoto Nishio, Kazuhiko Nakagawa, Makoto Maemondo, Akira Inoue, Toyoaki Hida, Nobuyuki Yamamoto, Hiroshige Yoshioka, Masao Harada, Yuichiro Ohe, Naoyuki Nogami, Kengo Takeuchi, Tadashi Shimada, Tomohiro Tanaka, Tomohide Tamura, CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study Lancet Oncology. ,vol. 14, pp. 590- 598 ,(2013) , 10.1016/S1470-2045(13)70142-6